Weil am Rhein, Germany

Simone Plattner

USPTO Granted Patents = 1 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Simone Plattner

Introduction

Simone Plattner is an innovative inventor based in Weil am Rhein, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that have therapeutic applications. Her work reflects a deep commitment to advancing healthcare through scientific innovation.

Latest Patents

Simone holds a patent for "Bicyclic Compounds and Their Uses." This groundbreaking invention provides a compound, or a pharmaceutically acceptable salt thereof, of a specific formula. It outlines various therapeutic uses of the compounds, their applications as research chemicals, pharmaceutical compositions, and methods for manufacturing these compounds. This patent highlights her expertise in chemical innovation within the pharmaceutical industry.

Career Highlights

Simone Plattner is currently employed at Novartis AG, a global healthcare company renowned for its research and development in pharmaceuticals. At Novartis, she works at the forefront of medical science, contributing to the development of important therapeutic agents that address various health challenges.

Collaborations

Throughout her career, Simone has collaborated with notable colleagues, including Vincent Bordas and Jvan Brun. These partnerships showcase her ability to work effectively in a team-oriented environment, combining diverse skills and insights to enhance the innovation process.

Conclusion

Simone Plattner's contributions to the field of pharmaceutical chemistry exemplify the impact that a dedicated inventor can have on healthcare advancements. Her patent for bicyclic compounds demonstrates her innovative spirit and commitment to improving patient outcomes through scientific research. As she continues her work at Novartis AG, the future holds great potential for further breakthroughs in her area of expertise.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…